Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - TOTAL DEBT REPAID
Total Debt Repaid AKBA - Akebia Therapeutics, Inc.
-32 M
LAST VALUE
0.00%
2 YEAR CAGR
-341.85%
5 YEAR CAGR
0.00%
10 YEAR CAGR